The LiDCOrapid enables clinicians to optimally deliver goal directed management (GDM) strategies. It does this by utilizing its patented and clinically validated PulseCO algorithm 2-9. It provides immediate feedback on a patient's fluid and hemodynamic status. It offers a clear indication of therapeutic route, whether it is fluid or drug, and gives an early and fast warning of change. The LiDCOrapid quantifies the hemodynamic response, particularly the stroke volume. It makes more effective use of the fluids, using the right amount at the right time. The system contributes to reduced morbidity and complications, particularly infections. It is able to reduce the overall cost of care and the length of stay.